Panarotto D, Poisson J, Devroede G, Maheux P
Department of Medicine, Université de Sherbrooke, Quebec, Canada.
Metabolism. 2000 Sep;49(9):1224-7. doi: 10.1053/meta.2000.8624.
Adipose tissue synthesizes lipoprotein lipase (LPL), which helps in the postprandial clearance of triglyceride-rich lipoproteins. Because visceral adipose tissue is generally accepted as the most important metabolic tissue, we sought to verify whether there are regional differences in the expression of LPL. Samples of adipose tissue from subcutaneous and omental fat deposits were obtained from 20 adults undergoing surgery. Total adipose tissue LPL activity was measured using a conventional radioactive substrate assay. Steady-state levels of LPL mRNA were assessed using the very sensitive RNase protection assay technique with 18S ribosomal RNA as an internal control. A correlation was demonstrated between LPL activity levels in subcutaneous and omental tissue (r = .72; P < .01) and between mRNA levels at both sites (r = .47, P = .04). LPL mRNA levels were significantly lower in omental compared with subcutaneous depots (omental v subcutaneous, 1.7 +/- 0.7 v 2.1 +/- 0.7 arbitrary units [AU] over 18S, P < .05). In paired comparisons, LPL mRNA levels in omental adipose tissue were, on average, 20% +/- 7% (range, -57% to +9.0%) lower than the levels measured in subcutaneous adipose tissue (P < .05). In conclusion, these data suggest that subcutaneous adipose tissue is a reliable surrogate of the expression (activity and mRNA) of LPL in omental adipose tissue, even though omental depots express proportionally less LPL than subcutaneous depots.
脂肪组织合成脂蛋白脂肪酶(LPL),该酶有助于餐后清除富含甘油三酯的脂蛋白。由于内脏脂肪组织通常被认为是最重要的代谢组织,我们试图验证LPL的表达是否存在区域差异。从20名接受手术的成年人身上获取皮下和网膜脂肪沉积处的脂肪组织样本。使用传统的放射性底物分析法测量总脂肪组织LPL活性。采用非常灵敏的核糖核酸酶保护分析技术,以18S核糖体RNA作为内对照,评估LPL mRNA的稳态水平。皮下和网膜组织中LPL活性水平之间存在相关性(r = 0.72;P < 0.01),两个部位的mRNA水平之间也存在相关性(r = 0.47,P = 0.04)。与皮下脂肪库相比,网膜中的LPL mRNA水平显著更低(网膜与皮下相比,相对于18S,分别为1.7 ± 0.7和2.1 ± 0.7任意单位[AU],P < 0.05)。在配对比较中,网膜脂肪组织中的LPL mRNA水平平均比皮下脂肪组织中测得的水平低20% ± 7%(范围为 - 57%至 + 9.0%)(P < 0.05)。总之,这些数据表明,皮下脂肪组织是网膜脂肪组织中LPL表达(活性和mRNA)的可靠替代指标,尽管网膜脂肪库中LPL的表达比例低于皮下脂肪库。